Loading...
Evaluating a novel treatment for coronary artery inflammation in acute Kawasaki disease: A Phase I/IIa trial of atorvastatin
INTRODUCTION: Since the 1980s, the primary treatment of acute Kawasaki disease (KD) has been intravenous immunoglobulin and aspirin. However, 5-10% of children with acute KD will develop coronary artery abnormalities despite treatment within the first ten days after fever onset. There is no approved...
Na minha lista:
| Udgivet i: | Expert Opin Orphan Drugs |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4979608/ https://ncbi.nlm.nih.gov/pubmed/27525197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/21678707.2015.1066246 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|